» Articles » PMID: 31878022

Amino Acid Transport Defects in Human Inherited Metabolic Disorders

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Dec 28
PMID 31878022
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Amino acid transporters play very important roles in nutrient uptake, neurotransmitter recycling, protein synthesis, gene expression, cell redox balance, cell signaling, and regulation of cell volume. With regard to transporters that are closely connected to metabolism, amino acid transporter-associated diseases are linked to metabolic disorders, particularly when they involve different organs, cell types, or cell compartments. To date, 65 different human solute carrier (SLC) families and more than 400 transporter genes have been identified, including 11 that are known to include amino acid transporters. This review intends to summarize and update all the conditions in which a strong association has been found between an amino acid transporter and an inherited metabolic disorder. Many of these inherited disorders have been identified in recent years. In this work, the physiological functions of amino acid transporters will be described by the inherited diseases that arise from transporter impairment. The pathogenesis, clinical phenotype, laboratory findings, diagnosis, genetics, and treatment of these disorders are also briefly described. Appropriate clinical and diagnostic characterization of the underlying molecular defect may give patients the opportunity to avail themselves of appropriate therapeutic options in the future.

Citing Articles

Rescue of cochlear vascular pathology prevents sensory hair cell loss in Norrie disease.

Patel A, Pauzuolyte V, Ingham N, Leong Y, Berger W, Steel K Proc Natl Acad Sci U S A. 2024; 121(49):e2322124121.

PMID: 39585982 PMC: 11626139. DOI: 10.1073/pnas.2322124121.


Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta-Analysis.

Zhang Y, Zhang J, Zhan Y, Pan Z, Liu Q, Yuan W J Cachexia Sarcopenia Muscle. 2024; 15(6):2295-2310.

PMID: 39529263 PMC: 11634529. DOI: 10.1002/jcsm.13629.


The role of double heterozygotes of SLC3A1 and SLC7A9 in the prevalence of cystine stones.

Wu C, Patel I, Lovrenert K, Eisner B, Meeks N, Chun-Hui Tsai A Genet Med. 2024; 27(1):101281.

PMID: 39315525 PMC: 11717588. DOI: 10.1016/j.gim.2024.101281.


metaExpertPro: A Computational Workflow for Metaproteomics Spectral Library Construction and Data-Independent Acquisition Mass Spectrometry Data Analysis.

Sun Y, Xing Z, Liang S, Miao Z, Zhuo L, Jiang W Mol Cell Proteomics. 2024; 23(10):100840.

PMID: 39278598 PMC: 11795700. DOI: 10.1016/j.mcpro.2024.100840.


Amino acid metabolism in kidney health and disease.

Knol M, Wulfmeyer V, Muller R, Rinschen M Nat Rev Nephrol. 2024; 20(12):771-788.

PMID: 39198707 DOI: 10.1038/s41581-024-00872-8.


References
1.
Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G . Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J Med Genet. 2008; 45(5):314-8. DOI: 10.1136/jmg.2007.055475. View

2.
Knoll T, Zollner A, Wendt-Nordahl G, Michel M, Alken P . Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol. 2004; 20(1):19-24. DOI: 10.1007/s00467-004-1663-1. View

3.
Choi K, Jen J, Choi S, Shin J, Kim H, Kim H . Late-onset episodic ataxia associated with SLC1A3 mutation. J Hum Genet. 2016; 62(3):443-446. DOI: 10.1038/jhg.2016.137. View

4.
. De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. Am J Hum Genet. 2016; 99(2):287-98. PMC: 4974067. DOI: 10.1016/j.ajhg.2016.06.003. View

5.
Rhodes H, Yarram-Smith L, Rice S, Tabaksert A, Edwards N, Hartley A . Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol. 2015; 10(7):1235-45. PMC: 4491297. DOI: 10.2215/CJN.10981114. View